Evidence map›Paper›PMID 42067840›Full record

ArticleLipids in health and disease2026

Unmasking residual cardiovascular risk: the paradoxical interaction between remnant cholesterol and calculated LDL-C in a tertiary-care cohort.

Hazar Gözgöz, Seher Kabul, Özlem Gürsoy Doruk

Abstract read
In one paragraph

Article in Lipids in health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hazar GözgözDepartment of Clinical Biochemistry, Türkoğlu Dr. Kemal Beyazıt State Hospital, Kahramanmaraş, Turkey.ORCID http://orcid.org/0000-0001-8388-8807
Seher KabulDepartment of Clinical Biochemistry, Bitlis State Hospital, Bitlis, Turkey.ORCID http://orcid.org/0000-0003-2077-4815
Özlem Gürsoy DorukFaculty of Medicine, Department of Clinical Biochemistry, Dokuz Eylul University, Izmir, Turkey. ozlem.gursoy@deu.edu.tr.ORCID http://orcid.org/0000-0002-1312-3777

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResidual atherosclerotic cardiovascular disease (ASCVD) risk often remains even after low-density lipoprotein cholesterol (LDL-C) levels have been brought down to target levels. Remnant cholesterol (RC) and inflammation have been increasingly linked to the residual risk. We aimed to investigating whether the discriminative value of RC the ability of RC to discriminate and its claimed interactions with LDL-C are due to a real clinical phenotype or are affected by formula-dependent biases between the Friedewald and Sampson-NIH equations.

methodsWe performed a cross-sectional analysis of consecutively tested adults (n = 3,342) using residual serum samples from routine clinical monitoring. To reduce analytical variability, all lipid profiles were analyzed using a single, dedicated reagent lot. We contrasted risk models with Friedewald-calculated versus Sampson-NIH-calculated LDL-C to assess equation-dependent differences. Lipid parameters, hemoglobin A1c (HbA1c), estimated glomerular filtration rate (eGFR), and C-reactive protein (CRP) were measured. ASCVD was defined using International Classification of Diseases, 10th Edition (ICD-10) codes. Missing covariate data were handled using multiple imputation by chained equations (m = 50), with additional complete-case sensitivity analyses for CRP-related models. To reduce bias, the observed ASCVD status was included as an auxiliary variable; the outcome itself was not imputed. The discriminative performance of nested logistic regression models was assessed through the pooled area under the receiver operating characteristic curve (AUC) and pooled DeLong p-values.

resultsThe primary clinical focus was the presence of documented pre-existing ASCVD diagnoses, identified in 11.4% of the cohort, while 9.4% of participants met the criteria for atherogenic dyslipidemia (AD). In the primary analysis with Friedewald LDL-C, we detected a statistically significant (p < 0.001) negative interaction between LDL-C and RC, while logCRP remained an independent correlate in the adjusted model. Interestingly, when we verified this using the more accurate Sampson-NIH equation to minimize the possibility that the result would be solely due to calculation bias, the paradoxical interaction was still statistically significant (p = 0.003) along with a strong model performance (AUC: 0.729). This indicates that the interaction is not entirely explained by the mathematical artifact of the Friedewald formula, but rather represents a consistent statistical pattern in this cohort.

conclusionRC adds statistically significant value to risk discrimination. The continuous inverse relationship of LDL-C with high RC identifies a statistical pattern consistent with persistent atherogenic burden despite apparently optimal calculated LDL-C levels. Awareness of this potential suppressor effect may aid in refining risk stratification in tertiary-care settings.

Indexed as

AtherosclerosisCardiovascular DiseasesCholesterolCholesterol, LDLTriglyceridesAdultAgedC-Reactive ProteinCross-Sectional StudiesFemaleGlomerular Filtration RateGlycated HemoglobinHeart Disease Risk FactorsHumansMaleMiddle AgedCholesterolCholesterol, LDLC-Reactive ProteinGlycated HemoglobinTriglyceridesEquation-dependent biasFriedewald equationPrevalent ASCVD discriminationRemnant cholesterolSampson-NIH equation

Identifiers

PMID42067840
PMCPMC13281486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.